CD28 and type 2 diabetes mellitus: al showed that advanced glycation end products (AGEs) effectively enhanced these subset T cells proliferation in patients with T2DM, and the higher level of CD4 + CD28- T cells is closely associated with the status of macrovascular atherosclerosis in patients with T2DM [62].